18 April 2016
Shining Light on Brain Tumors
New Method Allows Surgeons to Identify Brain Tumors in Real Time
WASHINGTON — When operating on cancer, surgeons want to remove tumors and not healthy tissue. This is especially important and challenging when dealing with brain tumors, which are often spread out and mixed in with the healthy tissue. Now, researchers have shown that a well-established optics technique can reveal exactly where brain tumors are, producing images in less than a minute — unlike conventional methods that can take a whole day.
"The special thing about our images is that we showed they contain so much information," said Marloes Groot of VU University Amsterdam
, Netherlands. "When I showed these images to the pathologists that we work with, they were amazed." Groot and her colleagues describe their work in the journal Biomedical Optics Express,
from The Optical Society
|Tissue from a patient diagnosed with low-grade glioma. The green image is taken with the new method, while the pink uses conventional hematoxylin and eosin staining. Going from the upper left to the lower right, both images show increasing cell density due to more tumor tissue. The insets reveal the high density of tumor cells.Image credit: N.V. Kuzmin et al, VU University Amsterdam
Pathologists typically use staining methods, in which chemicals like hematoxylin and eosin turn different tissue components blue and red, revealing its structure and whether there are any tumor cells. But for a definitive diagnosis this process can take up to 24 hours, which means surgeons may not realize some cancerous tissue has escaped from their attention until after surgery — requiring a second operation and more risk.
But with the new technique, the researchers don't use any labeling or staining at all. Instead, they fire short, 200-femtosecond-long laser pulses into the tissue, and when three photons converge at the same time and place, the photons interact with the nonlinear optical properties of the tissue. Through well-known phenomena in optics called second and third harmonic generation, these interactions produce a single photon.
The key is that the incoming and outgoing photons have different wavelengths. The incoming photons are at 1200 nanometers, long enough to penetrate deep into the tissue. The single photon that is produced, however, is at 600 or 400 nanometers, depending on if it's second or third harmonic generation. The shorter wavelengths mean the photon can scatter in the tissue. The scattered photon thus contains information about the tissue, and when it reaches a detector, in this case a high-sensitivity GaAsP photomultiplier tube, it reveals what the tissue looks like inside.
While other researchers have exploited this technique for other applications — to make images of insects and fish embryos, for example — this is the first time anyone has used it to analyze glial brain tumors. These tumors are particularly deadly because it's hard to get rid of tumor cells by surgery, irradiation, and chemotherapy without substantial collateral damage to the surrounding brain tissue.
The researchers tested their method on samples of glial brain tumors from humans, finding that the histological detail in these images was as good — if not better — than those made with conventional staining techniques. They were able to make most images in under a minute. The smaller ones took less than a second, while larger images of a few square millimeters took five minutes. "This makes it possible to do it in real time in the operating room," Groot said.
Now that they've shown their approach works, the researchers are developing a hand-held device that a surgeon can use to identify a tumor's border during surgery. The incoming laser pulses can only reach a depth of about 100 micrometers into the tissue. To reach farther, Groot envisions attaching a needle that can pierce the tissue and deliver photons deeper.
"With our technique it's potentially possible to diagnose not only during an operation but possibly before surgery," she said.
Paper: N. Kuzmin, P. Wesseling, C. de Witt Harner, D. Noske, G. Galgano, D. Mansvelder, J. Baayen and M.L. Groot. "Third Harmonic Generation Imaging for Fast, Label-Free Pathology of Human Brain Tumors," Biomedical Optics Express
, Vol. 7, Issue 5, 1889-1904. DOI:10.1364/BOE.7.001889
About Biomedical Optics Express
Biomedical Optics Express
is OSA’s principal outlet for serving the biomedical optics community with rapid, open-access, peer-reviewed papers related to optics, photonics and imaging in the life sciences. The journal scope encompasses theoretical modeling and simulations, technology development, and biomedical studies and clinical applications. It is published by The Optical Society and edited by Christoph Hitzenberger, Medical University of Vienna. Biomedical Optics Express is an open-access journal and is available at no cost to readers online at: OSA Publishing
About The Optical Society
Founded in 1916, The Optical Society (OSA) is the leading professional organization for scientists, engineers, students and entrepreneurs who fuel discoveries, shape real-life applications and accelerate achievements in the science of light. Through world-renowned publications, meetings and membership initiatives, OSA provides quality research, inspired interactions and dedicated resources for its extensive global network of optics and photonics experts. For more information, visit osa.org/100.